Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
148.9 USD | -0.46% | +2.78% | -5.07% |
02:08pm | Alvotech’s Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study | MT |
Apr. 22 | J&J: EU green light for Carvykti in multiple myeloma | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.07% | 360B | |
+25.54% | 672B | |
+25.87% | 570B | |
+16.83% | 321B | |
+8.41% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.74% | 149B | |
-4.96% | 147B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Unit Secures FDA's Breakthrough Therapy Designation For Talquetamab in Multiple Myeloma